Home › NDC Lookup › RxCUI directory › RxCUI 1297944

Coal tar 0.02 MG/MG Topical Ointment [Revitaderm Psoriasis] — RxCUI 1297944

RxNorm drug concept · Semantic branded drug
RxCUI 1297944 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1297944
Official nameCoal tar 0.02 MG/MG Topical Ointment [Revitaderm Psoriasis]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRevitaderm Psoriasis 0.02 MG/MG Topical Ointment; RevitaDERM PSORIASIS 2 % Topical Ointment; Revitaderm Psoriasis (coal tar 2 % ) Topical Ointment
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Coal Tar: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves the itching, scaling, flaking and redness of psoriasis, seborrheic dermatitis and dandruff. Which of these a product treats depends on the brand, so check your package....
  • It depends on the product. Most coal tar shampoos say to use them at least twice a week, leaving the lather on for several minutes. Some ointments, gels and lotions can be used one...
  • Be careful. Coal tar can make you more likely to sunburn for up to 24 hours after you apply it. Cover up and limit sun exposure during that time.
  • Don't combine it with light therapy or prescription psoriasis medicines unless your doctor says it's okay. Check with me or your doctor first if you're not sure.
📖 Read our full Coal Tar guide →

🕸️ Concept Web — How Coal tar 0.02 MG/MG Topical Ointment [Revitaderm... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Coal tar 0.02 MG/MG Topical Ointment [Revitaderm Psoriasis] RxCUI 1297944

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Coal tar 2635
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Revitaderm Psoriasis 1297940
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Coal tar Topical Ointment 374562
    • Coal tar Topical Product 1154205
    • Coal tar Topical Ointment [Revitaderm Psoriasis] 1297942
    • Revitaderm Psoriasis Topical Product 1297943
    • Topical Ointment 316985
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Coal tar 0.02 MG/MG [Revitaderm Psoriasis] SBDC · 1297941
  • Coal tar Topical Ointment [Revitaderm Psoriasis] SBDF · 1297942
  • Revitaderm Psoriasis Topical Product SBDG · 1297943
  • Revitaderm Psoriasis BN · 1297940

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1297944 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63347-0112-01 118 mL in 1 JAR (63347-112-01) RevitaDERM PSORIASIS Blaine Labs Inc. 2011-11-01
Observed labelers: Blaine Labs Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.